Live Breaking News & Updates on Bret Jensen|Page 3

Stay updated with breaking news from Bret jensen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

RGLS stock surges after Phase 1 data for kidney disease candidate (NASDAQ:RGLS)

The shares of clinical-stage biotech Regulus Therapeutics Inc ....

Bret Jensen , Regulus Therapeutics Inc , Regulus Therapeutics , Ascending Dose , Autosomal Dominant Polycystic Kidney Disease , Multiple Ascending Dose , Seeking Alpha ,

3 Healthcare Stocks You Can Target

Owning these healthcare stocks could be rewarding during market uncertainty. ....

Buffett Berkshire Hathway , Bristol Myer Squibb , Stifel Nicolaus , Warren Buffett , Stephen Guilfoyle , Bret Jensen , Bayer Nexavar , Mckesson Co , Federal Reserve , National Comprehensive Cancer Network , Cancer Therapy Company Is Small , Trade Has My Attention , Berkshire Hathway , Option Look Big , Money Pro , All Smarts ,

What Inflation Means To Investors Now

An 8.6% increase in inflation last month means an unfriendly Fed will continue to be a headwind to stock prices ....

Raphael Bostic , Helene Meisler , Bret Jensen , National Association Of Active Investment , Atlanta Fed President Raphael Bostic , Real Money Pro Doug Kas , Inflation Isnt Going Anywhere , Money Pro , Wall Street , Careful What You Wish For , Investors Intelligence , National Association , Active Investment Manager Exposure , Same Old Market , Hi Lo Indicator , Presidential Election , Stock Trader , All Smarts ,

These Could Be the Worst Stocks In A Recession

If a recession is inevitable, history suggests these could be the worst performing sectors. ....

United States , Bret Jensen , Action Alerts , Cass Freight Index , Confidence Is Shot , Money Pro , Nerd Wallet , Conference Board , All Smarts ,

Jensen: BioMarin Is a Synthetic Dividend Play

Using options to play the trading range in drug developer proves profitable. ....

Bret Jensen , Biomarin Pharmaceuticals , Drug Administration , Real Money , Federal Drug Administration , Short Form Insight ,